Immune Checkpoint Inhibitor Clinical Trials in Chongqing
2 recruitingChongqing, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)
Non-small Cell Lung CancerImmune Checkpoint Inhibitors (ICIs)
Second Xiangya Hospital of Central South University70 enrolled20 locationsNCT06951646
Recruiting
Not Applicable
Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
Lung CancerRadiotherapyImmune Checkpoint Inhibitor
Xinqiao Hospital of Chongqing40 enrolled2 locationsNCT05754203